24 results found on lung cancer
Select a condition to view medications used to treat that condition
- anaplastic lymphoma kinase positive non-small cell lung cancer
- egfr negative, alk negative, non-small cell lung cancer
- egfr t790m mutation-positive non-small cell lung cancer
- epidermal growth factor receptor positive non-small cell lung cancer
- extensive-stage small cell lung cancer
- malignant neoplasm of lung
- metastatic non-small cell lung cancer with egfr exon 19 deletion
- metastatic non-small cell lung cancer with egfr exon 21 l858r substitution mutation
- non-small cell lung cancer
- non-small cell lung cancer with braf v600e mutation
- non-small cell lung cancer with egfr exon 19 deletion
- non-small cell lung cancer with egfr exon 20 insertion mutation
- non-small cell lung cancer with egfr exon 21 l858r substitution mutation
- non-small cell lung cancer with kras g12c mutation
- non-small cell lung cancer with mesenchymal-epithelial transition (met) exon 14 skipping
- nonsquamous non-small cell lung cancer
- pd-l1 positive non-small cell lung cancer
- pd-l1 positive, egfr-negative, alk-negative metastatic non-small cell lung cancer
- pd-l1 positive, egfr-negative, alk-negative, ros1-negative non-small cell lung cancer
- prevention of chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer
View More
- anaplastic lymphoma kinase positive non-small cell lung cancer
- egfr negative, alk negative, non-small cell lung cancer
- egfr t790m mutation-positive non-small cell lung cancer
- epidermal growth factor receptor positive non-small cell lung cancer
- extensive-stage small cell lung cancer
- malignant neoplasm of lung
- metastatic non-small cell lung cancer with egfr exon 19 deletion
- metastatic non-small cell lung cancer with egfr exon 21 l858r substitution mutation
- non-small cell lung cancer
- non-small cell lung cancer with braf v600e mutation
View More